Acyclovir Ophthalmic and Dichlorphenamide: Interaction Details
- Acyclovir Ophthalmic
- AvaclyrSitavigZovirax
- Dichlorphenamide
- KeveyisOrmalvi
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Acyclovir Ophthalmic and Dichlorphenamide interaction:
Acyclovir Ophthalmic
- Avaclyr
- Sitavig
- Zovirax
Dichlorphenamide
- Keveyis
- Ormalvi
What Happens When You Take Acyclovir Ophthalmic With Dichlorphenamide
What can happen when they are taken together (rated Major)
Increased OAT1 exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving dichlorphenamide, an of OAT1, together with drugs that are OAT1 substrates is not recommended, because the combination may raise exposure to the OAT1 substrate.1
The Acyclovir Ophthalmic and Dichlorphenamide Interaction, Explained
Dichlorphenamide (used for certain rare muscle conditions) can slow down a pathway in your kidneys, called OAT1, that helps clear some medicines from your body. Acyclovir is one of the medicines cleared this way, so in theory more of it could build up.
The good news: this warning is theoretical, and acyclovir used in or around the eye reaches the blood only in very small amounts. Still, the combination is labeled "not recommended," so it is worth a quick check. Keep using both as prescribed and let your pharmacist or doctor know you take both. Your care team can review this and keep an eye on you.
Mechanism: Dichlorphenamide inhibits organic anion 1 (OAT1). Acyclovir is an OAT1 eliminated largely by renal tubular secretion, so may increase acyclovir systemic exposure (/).
- Severity on file: major. The dichlorphenamide labeling lists coadministration with OAT1 substrates as not recommended.
- Evidence: theoretical. No acyclovir-specific data are available, and the onset is unspecified.
- Context: Ophthalmic acyclovir (ointment, Avaclyr) yields minimal systemic , so clinical relevance is likely low. Buccal Sitavig is a separate formulation with more systemic absorption.
- Management: Review whether the combination is needed or an alternative is appropriate. If it is continued, monitor for acyclovir toxicity (renal function, effects), especially in patients with renal impairment.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Acyclovir Ophthalmic and Dichlorphenamide Interact
The likely mechanism
of OAT1 transport by dichlorphenamide
How to Manage the Acyclovir Ophthalmic and Dichlorphenamide Interaction
The official guidance says using dichlorphenamide together with medicines like acyclovir is not recommended, because acyclovir could build up in the body. With eye forms of acyclovir, very little reaches the blood.
- Keep using both medicines exactly as prescribed. Do not stop either one on your own.
- Tell your pharmacist and prescriber that you use both.
- Your care team may decide whether an alternative makes sense, or they may simply monitor you more closely.
- Ask whether kidney problems you have might matter here.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Acyclovir Ophthalmic or Dichlorphenamide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Acyclovir Ophthalmic and Dichlorphenamide: Common Questions
How serious is the Acyclovir Ophthalmic and Dichlorphenamide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Acyclovir Ophthalmic and Dichlorphenamide interaction managed?
The official guidance says using dichlorphenamide together with medicines like acyclovir is not recommended, because acyclovir could build up in the body. With eye forms of acyclovir, very little reaches the blood. Keep using both medicines exactly as prescribed. Do not stop either one on your own. Tell your pharmacist and prescriber that you use both. Your care team may decide whether an alternat… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Acyclovir Ophthalmic and Dichlorphenamide Interaction
Ask in your own words about taking Acyclovir Ophthalmic and Dichlorphenamide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: KEVEYIS(R) oral tablets, dichlorphenamide oral tablets. Strongbridge US Inc. (per FDA), Trevose, PA, 2019. DailyMed
Other Serious Interactions of Acyclovir Ophthalmic and Dichlorphenamide
Also serious with Acyclovir Ophthalmic
Also serious with Dichlorphenamide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dichlorphenamide
- Activated CharcoalMajor
- AlfalfaModerate
- St. John's WortModerate
- ChlorellaModerate
- Slippery ElmModerate
- GlucomannanModerate
- TragacanthModerate
- Angelica ArchangelicaModerate
- + 29 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.